SynBioBeta Speaker
Juliette Humer
Muse Bio
Founder & CEO
Juliette Humer is founder and CEO of Muse Bio, pioneering a new frontier in regenerative medicine by transforming menstrual blood into a globally scalable, affordable, and ethical source of stem cells. Inspired by her own recovery journey from a spinal injury in her early twenties, Juliette turned a deeply personal medical need into a bold vision—one that slashes the cost of 100 million stem cells from $100,000 to just $1,000 through non-invasive, at-home collection.
She brings a strong academic foundation in biochemistry and environmental health from Hampshire College, where she studied the intersection of toxicology and molecular biology.
In under a year, she’s raised $1.1M in pre‑seed funding from top-tier investors including Draper VC and Boost VC, built a world-class team, secured lab space, and joined leading biotech accelerators like Nucleate and Infinita. Muse Bio now supports over 1,000 people on its biobanking waitlist, has LOIs with more than a dozen biotech partners, and resonates with more than a million people across social platforms—especially women ready to reclaim agency in their healthcare.
At 30, Juliette isn’t just innovating in the lab—she’s creating the future supply chain of regenerative medicine, blending scientific rigor with system-level impact and a deeply personal mission.
SynBioBeta 2026 Tickets are Live
Confirmed Speakers
Sessions Featuring
Juliette
This Year
Session lineup still growing
Purchase Pass
Featuring
Speaker Coming Soon
•
-
Human Health
From Cells to Patients: Solving the Scale Mismatch in Virtual Biology
Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?
Purchase Pass
Featuring
Speaker Coming Soon
